Today: 20 May 2026
Astronics (ATRO) stock rises again after Q4 revenue update and 2026 sales forecast

Astronics (ATRO) stock rises again after Q4 revenue update and 2026 sales forecast

NEW YORK, January 9, 2026, 10:09 EST — Regular session

  • Shares climbed roughly 1.7% in morning action, building on an 11.3% surge from the previous session.
  • The company projected fourth-quarter revenue between $236 million and $239 million, with bookings coming in around $257 million.
  • Investors want details from the full quarterly report, especially to see if those orders will actually turn into revenue for 2026.

Astronics Corp (ATRO.O) traded up roughly 1.7% to $65.88 Friday morning, after touching $67.19 earlier. The stock had surged 11.3% the previous day, lifted by a fresh preliminary sales update and the company’s new 2026 revenue goal, reports.

Astronics reported that its unaudited fourth-quarter revenue landed between $236 million and $239 million, topping earlier guidance. That midpoint marks a 14% year-over-year increase. The company logged about $257 million in bookings, putting 2025 orders around $924 million. Full-year revenue: roughly $860 million, showing an 8% gain from 2024. Management projects 2026 revenue will fall between $950 million and $990 million. CEO Peter Gundermann says he expects that “the momentum to continue in 2026,” with higher volume set to boost both profitability and cash flow, though he emphasized these results are still preliminary. Business Wire

The mid-range guide for 2026 points to about 13% growth over 2025’s $860 million. Meanwhile, fourth-quarter bookings came in stronger than sales, with the “book-to-bill” ratio landing around 1.1. That tells you order intake is running above shipments for now.

The company submitted the revised Form 8-K to the U.S. Securities and Exchange Commission on Thursday, according to the .

The surge sent ATRO beyond what some analysts expected. According to , the stock just broke through the average 12-month target price of $60.75. Analyst targets cluster between $58 and $65.

What comes next: we get granular. Margins, cash flows, and — crucial — conversion of backlog to actual shipments as the new year unfolds. Traders now want a new look at the revenue range, but they’ll have to wait until the books are officially shut.

Still, the update is preliminary and hasn’t been audited. Aerospace orders often arrive in clusters or get pushed back, too. If aircraft production rates slow down, or customer approvals and deliveries hit snags, reaching that 2026 target could become tougher.

Astronics hasn’t locked in a date for its Q4 report yet, though MarketBeat is projecting March 3 after the bell. That update is expected to bring sharper detail on the 2026 targets and booking trends, according to .

Stock Market Today

  • Trump's Truth Social Withdraws Bitcoin and Bitcoin-Ethereum ETF Applications Amid Market Pressure
    May 20, 2026, 7:22 AM EDT. Trump Media & Technology Group has withdrawn its applications for Bitcoin and Bitcoin-Ethereum exchange-traded funds (ETFs), citing a strategic shift to pursue a different regulatory framework under the Investment Company Act of 1940 ('40 Act) instead of the Securities Act of 1933 ('33 Act). Yorkville America, the investment advisor, highlighted that the '40 Act allows more flexible investment strategies. This move comes amid intense fee competition in the U.S. spot Bitcoin ETF market, valued at $57.4 billion since January 2024, following Morgan Stanley's MSBT launch, which offers a low 0.14% expense ratio. The withdrawal underscores heightened competition and evolving regulatory approaches in the crypto ETF space.

Latest articles

InMed Pharmaceuticals (INM) Stock Doubled on Mentari Merger — Why the Rally Is Already Being Tested

InMed Pharmaceuticals (INM) Stock Doubled on Mentari Merger — Why the Rally Is Already Being Tested

20 May 2026
InMed Pharmaceuticals shares fell 14.4% to $1.37 in early pre-market trading Wednesday, after surging 135% Tuesday on news of an all-stock merger with Mentari Therapeutics and a planned $290 million private placement. Pre-merger InMed shareholders are expected to own about 1.51% of the combined company, which will operate as Mentari Therapeutics and focus on migraine drug development.
Micware Shares Swing Pre-Market After 26% Drop on Nasdaq Debut

Micware Shares Swing Pre-Market After 26% Drop on Nasdaq Debut

20 May 2026
Micware shares jumped 97.7% to $9.33 in premarket U.S. trading Wednesday, rebounding above last week’s $8 IPO price after closing Tuesday at $4.72. A new SEC filing showed Toyota owns 11.6% of Micware’s ordinary shares. The Japanese automotive software firm raised $22.8 million in its Nasdaq debut last week.
Dow edges up while Nasdaq falls as bond worries drag on

Futures Edge Higher Ahead of Nvidia Earnings as Wall Street Watches Key Report

20 May 2026
Nasdaq 100 futures rose 0.73% and S&P 500 futures gained 0.35% ahead of Wednesday’s open, with Nvidia set to report earnings after the close. Options markets priced in a 6.5% swing for Nvidia, equal to about $355 billion in market value. In premarket trading, Nvidia shares rose 1.84%, while Micron, Intel, and AMD also advanced. Fed minutes are due at 2:00 p.m. EDT.
Sensex, Nifty slump for fifth day — what’s spooking India’s stock market right now
Previous Story

Sensex, Nifty slump for fifth day — what’s spooking India’s stock market right now

Kohl’s stock slides 5% as tariff ruling delay hits retailers; KSS traders eye Jan. 14
Next Story

Kohl’s stock slides 5% as tariff ruling delay hits retailers; KSS traders eye Jan. 14

Go toTop